How good is Lebanese cannabis? Scientists seek herbal remedies
By Ayat Basma BYBLOS, Lebanon (Reuters) – Locked away safely in an academic’s study in...
Read More
Author: Reuters
Bayer sees no reason to re-evaluate Monsanto legal risks
FRANKFURT (Reuters) – German drugmaker Bayer <BAYGn.DE> sees no reason to re-assess...
Read More
Novartis trial win lifts profile of new breast cancer drug
By John Miller ZURICH (Reuters) – Novartis’s efforts to tackle an elusive gene...
Read More
AstraZeneca inhaler lags GSK drug in lung disease trial
LONDON (Reuters) – A new AstraZeneca inhaler for chronic lung disease has proved worse than...
Read MoreChina reports fourth African swine fever outbreak as infection spreads south
By Josephine Mason and Hallie Gu BEIJING (Reuters) – China, home to the world’s largest pig herd, reported its fourth outbreak of the deadly African swine fever on Thursday, with more than 400 pigs infected as the...
Read More
Congo approves more experimental Ebola treatments as cases rise
KINSHASA (Reuters) – Democratic Republic of Congo has approved four more experimental...
Read More
Congo approves more experimental Ebola treatments
By Amedee Mwarabu KINSHASA (Reuters) – Democratic Republic of Congo has approved four more...
Read More
U.S. appeals court says GSK cannot be sued over generic drug suicide
By Tina Bellon (Reuters) – A U.S. appeals court on Wednesday tossed a $3 million verdict...
Read More
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
(Reuters) – Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would...
Read MoreSport specialization tied to injuries in kids and teens
By Lisa Rapaport (Reuters Health) – Children and teens who specialize in one sport may be more likely to get injured than those who play a variety of sports, a new study suggests. Researchers examined data from five...
Read More
Venezuelan mothers-to-be head to Brazil to give birth
By Nacho Doce BOA VISTA, Brazil (Reuters) – Expecting Venezuelan women are leaving their...
Read MoreFour in 10 women with asthma may develop COPD
By Shereen Lehman (Reuters Health) – Over 40 percent of women with asthma go on to develop more severe lung disease, a Canadian study suggests. Most of the risk factors for developing chronic obstructive pulmonary disease,...
Read MoreU.S. appeals court finds Alabama abortion law unconstitutional
By Jonathan Stempel (Reuters) – A federal appeals court on Wednesday upheld a permanent injunction blocking Alabama from banning the most common method of second-trimester abortion. But two judges from the 11th U.S....
Read More
Life expectancy declines seen in U.S. and other high-income countries
By Lisa Rapaport (Reuters Health) – Life expectancy is declining in high-income countries...
Read MoreE-cigarette vapor tied to changes in lung cells
(This version of the story corrects spelling of Weiner in paragraphs 10, 12 and 13) By Linda Carroll (Reuters Health) – The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while...
Read More
Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal
By Tina Bellon (Reuters) – A Missouri trial court judge has affirmed the massive $4.69...
Read MoreHeart-healthy lifestyle in old age tied to lower dementia risk
By Lisa Rapaport (Reuters Health) – Older adults who take care of their heart may be less likely to develop dementia than people who don’t focus on heart health, a French study suggests. Researchers focused on seven...
Read MoreBreastfeeding linked to lower stroke risk
By Linda Carroll (Reuters Health) – Breastfeeding may protect a woman from stroke later in life, and the benefit appears to increase with the length of time she nurses, a U.S. study suggests. Postmenopausal women who said...
Read More
Exclusive: Pharma sector warns Saudis on German drug curbs
By Noah Barkin and Caroline Copley BERLIN (Reuters) – European and U.S. pharmaceutical...
Read MoreExact Sciences surges after marketing deal with Pfizer for cancer test
By Tamara Mathias and Saumya Joseph (Reuters) – Exact Sciences Corp’s shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the...
Read More